Vivani Medical, Inc. entered into a Transition Funding, Support and Services Agreement with Cortigent, Inc., a subsidiary, to provide funds and services until December 31, 2024 or the IPO of Cortigent. They also presented slide presentations and issued a press release regarding the proposed IPO of Cortigent.